These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
306 related articles for article (PubMed ID: 9505208)
1. Protein bound polysaccharide PSK abrogates more efficiently experimental metastases derived from H-2 negative than from H-2 positive fibrosarcoma tumor clones. Algarra I; Collado A; Garrido F J Exp Clin Cancer Res; 1997 Dec; 16(4):373-80. PubMed ID: 9505208 [TBL] [Abstract][Full Text] [Related]
2. In vivo activation of NK cells induces inhibition of lung colonization of H-2 positive and H-2 negative fibrosarcoma tumor clones. Algarra I; Pérez M; Gaforio JJ; Gasca F; Garrido F Clin Exp Metastasis; 1994 Jan; 12(1):31-6. PubMed ID: 8287618 [TBL] [Abstract][Full Text] [Related]
3. Differential effect of protein-bound polysaccharide (PSK) on survival of experimental murine tumors. Algarra I; Collado A; Garcia Lora A; Garrido F J Exp Clin Cancer Res; 1999 Mar; 18(1):39-46. PubMed ID: 10374675 [TBL] [Abstract][Full Text] [Related]
4. Heterogeneity of MHC-class-I antigens in clones of methylcholanthrene-induced tumors. Implications for local growth and metastasis. Algarra I; Gaforio JJ; Garrido A; Mialdea MJ; Pérez M; Garrido F Int J Cancer Suppl; 1991; 6():73-81. PubMed ID: 2066185 [TBL] [Abstract][Full Text] [Related]
5. Effect of in vivo activation of natural killer (NK) cells by a tilorone analogue on the survival of mice injected intravenously with different experimental murine tumours. Algarra I; González A; Pérez M; Gaforio JJ; Garrido F Clin Exp Immunol; 1996 Mar; 103(3):499-505. PubMed ID: 8608652 [TBL] [Abstract][Full Text] [Related]
6. H-2 antigens and tumour-associated transplantation antigens in clones derived from a methylcholanthrene-induced BALB/c tumour: their influence on the generation in vitro and in vivo of the specific anti-tumour immune response. Pérez M; Garrido A; Algarra I; Caballero A; Delgado C; Collado MD; Fernández-Cruz E; Garrido F Exp Clin Immunogenet; 1989; 6(3):204-18. PubMed ID: 2631798 [TBL] [Abstract][Full Text] [Related]
7. NK sensitivity and lung clearance of MHC-class-I-deficient cells within a heterogeneous fibrosarcoma. Algarra I; Ohlén C; Perez M; Ljunggren HG; Klein G; Garrido F; Kärre K Int J Cancer; 1989 Oct; 44(4):675-80. PubMed ID: 2507453 [TBL] [Abstract][Full Text] [Related]
8. Generation and control of metastasis in experimental tumor systems; inhibition of experimental metastases by a tilorone analogue. Algarra I; Pérez M; Höglund P; Gaforio JJ; Ljunggren HG; Garrido F Int J Cancer; 1993 May; 54(3):518-23. PubMed ID: 8509228 [TBL] [Abstract][Full Text] [Related]
9. A weakly tumorigenic phenotype with high MHC class-I expression is associated with high metastatic potential after surgical removal of the primary murine fibrosarcoma. Pérez M; Algarra I; Ljunggren HG; Caballero A; Mialdea MJ; Gaforio JJ; Klein G; Kärre K; Garrido F Int J Cancer; 1990 Aug; 46(2):258-61. PubMed ID: 2116997 [TBL] [Abstract][Full Text] [Related]
10. [Antitumor effect of PSK (2): effector mechanism of the antimetastatic effect in the "double grafted tumor system"]. Ebina T; Kohya H Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 1):1847-53. PubMed ID: 3592718 [TBL] [Abstract][Full Text] [Related]
11. Synergistic defense system by cooperative natural effectors against metastasis of B16 melanoma cells in H-2-associated control: different behavior of H-2+ and H-2- cells in metastatic processes. Kawano Y; Taniguchi K; Toshitani A; Nomoto K J Immunol; 1986 Jun; 136(12):4729-34. PubMed ID: 3711664 [TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo interaction between murine fibrosarcoma cells and natural killer cells. Laybourn KA; Hiserodt JC; Abruzzo LV; Varani J Cancer Res; 1986 Jul; 46(7):3407-12. PubMed ID: 2939945 [TBL] [Abstract][Full Text] [Related]
13. Selective upregulation of MHC class I expression in metastatic colonies derived from tumor clones of a murine fibrosarcoma. Pedrinaci S; Algarra I; Garcia Lora A; Gaforio JJ; Perez M; Garrido F Int J Clin Lab Res; 1999; 29(4):166-73. PubMed ID: 10784379 [TBL] [Abstract][Full Text] [Related]
14. Effect of MHC class-I transfection on local tumor growth and metastasis in an H-2-negative clone derived from a chemically induced fibrosarcoma. Mialdea MJ; Martin J; Gaforio JJ; Algarra I; Pérez M; Gonzalez A; Ljunggren HG; Garrido F Int J Cancer; 1992 Aug; 52(1):153-8. PubMed ID: 1500219 [TBL] [Abstract][Full Text] [Related]
15. Analysis of metastatic spread and growth of tumor cells in mice with depressed natural killer activity by anti-asialo GM1 antibody or anticancer agents. Saijo N; Ozaki A; Beppu Y; Takahashi K; Fujita J; Sasaki Y; Nomori H; Kimata M; Shimizu E; Hoshi A J Cancer Res Clin Oncol; 1984; 107(3):157-63. PubMed ID: 6736102 [TBL] [Abstract][Full Text] [Related]
16. IFN-gamma-inducing factor/IL-18 administration mediates IFN-gamma- and IL-12-independent antitumor effects. Osaki T; Péron JM; Cai Q; Okamura H; Robbins PD; Kurimoto M; Lotze MT; Tahara H J Immunol; 1998 Feb; 160(4):1742-9. PubMed ID: 9469432 [TBL] [Abstract][Full Text] [Related]
17. Immunotherapy eradicates metastases with reversible defects in MHC class I expression. Garrido C; Romero I; Berruguilla E; Cancela B; Algarra I; Collado A; García-Lora A; Garrido F Cancer Immunol Immunother; 2011 Sep; 60(9):1257-68. PubMed ID: 21553283 [TBL] [Abstract][Full Text] [Related]
18. Antitumor effector mechanism at a distant site in the double grafted tumor system of PSK, a protein-bound polysaccharide preparation. Ebina T; Kohya H Jpn J Cancer Res; 1988 Aug; 79(8):957-64. PubMed ID: 3141330 [TBL] [Abstract][Full Text] [Related]
19. Role of organ-associated NK cells in decreased formation of experimental metastases in lung and liver. Wiltrout RH; Herberman RB; Zhang SR; Chirigos MA; Ortaldo JR; Green KM; Talmadge JE J Immunol; 1985 Jun; 134(6):4267-75. PubMed ID: 3989307 [TBL] [Abstract][Full Text] [Related]
20. Metastatic capacity of cloned T10 sarcoma cells that differ in H-2 expression: inverse relationship to their immunogenic potency. Katzav S; Segal S; Feldman M J Natl Cancer Inst; 1985 Aug; 75(2):307-18. PubMed ID: 3894752 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]